Bloomage Subsidiary Completes China Cosmetic Ingredient Filing For Lacto-N-Neotetraose

Oct 22, 2026

Leave a message

news-1536-1024

October Filing Adds LNnT to Bloomage's Cosmetics Portfolio

The October 22 listing identifies Beijing Huaxi Lingfutang as the filing company. It is the subsidiary's second new cosmetic ingredient filing, following its July 21 filing for 3′-sialyllactose sodium salt. Industry reporting identified three filers for LNnT by the time the October record was published. The milestone therefore marks the addition of LNnT to the Bloomage subsidiary's own cosmetics portfolio. For manufacturers sourcing the ingredient, the filing number identifies the specific record associated with the Beijing supplier, a useful distinction when several companies have filed the same named molecule.

 

Four Linked Sugars Define the Ingredient

Lacto-N-neotetraose belongs to a family of carbohydrates known as human milk oligosaccharides, or HMOs. It is a linear tetrasaccharide made up of two galactose units, one N-acetylglucosamine unit and one glucose unit. The order of the sugars and the bonds linking them define the molecule. That distinction matters when comparing LNnT with other HMOs in Bloomage's portfolio, because each has a different structure. For cosmetic ingredient developers, this gives LNnT a clear molecular identity around which to build raw material specifications and design formulation studies.

news-1536-1024

 

news-1536-1024

Bloomage Extends Its HMO Program into Personal Care

Bloomage Biotech's 2026 interim report described a development pipeline covering more than 10 individual HMOs, with seven having reached pilot or trial production. The group identified LNnT, 2′-fucosyllactose and 3′-sialyllactose sodium salt as priorities for regulatory work. It also reported that all three had secured Chinese authorization as new varieties of food additives. The October cosmetics filing adds a separate milestone for LNnT and gives all three compounds a cosmetic ingredient filing within the group. The sequence shows how Bloomage is developing the same family of ingredients for nutrition and personal care through separate regulatory pathways.

 

First Use in a Filed Cosmetic Starts Safety Monitoring

Under China's cosmetic ingredient framework, the three-year safety monitoring period begins when the first cosmetic product using the new ingredient is registered or filed. The ingredient filer monitors and evaluates its use and safety during that period. When another company uses the ingredient in a cosmetic, the ingredient filer confirms the association with the finished product's filing or registration through the regulatory platform. Ingredients that complete monitoring without safety concerns can be included in China's Inventory of Existing Cosmetic Ingredients. The October publication establishes the ingredient filing date, while the first product filing or registration determines the monitoring start date.

news-1536-1024

 

 

Send Inquiry